价值医疗视角下的中医药优势评价思路与方法

郭然; 曾典; 胡裕涵; 刘远立; 刘保延

doi:10.3981/j.issn.1000-7857.2023.14.002

科技导报 >

2023 , Vol. 41 >Issue 14: 14 - 21

DOI: https://doi.org/10.3981/j.issn.1000-7857.2023.14.002

专题：中医真实世界临床研究

价值医疗视角下的中医药优势评价思路与方法

郭然 ,
曾典 ,
胡裕涵 ,
刘远立 ,
刘保延

展开

1. 北京协和医学院卫生健康管理政策学院，北京 100010
2. 中国中医科学院，北京 100700

郭然，博士研究生，研究方向为卫生政策，电子信箱：ranguo_pumc@163.com

收稿日期: 2023-04-01

修回日期: 2023-05-12

网络出版日期: 2023-08-15

基金资助

中国医学科学院医学与科技创新工程项目（2021-I2M-1-046）

收起

Evaluation of the advantage of Traditional Chinese Medicine from the perspective of value-based healthcare

GUO Ran ,
ZENG Dian ,
HU Yuhan ,
LIU Yuanli ,
LIU Baoyan

Expand

1. School of Health Policy and Management, Peking Union of Medical College, Beijing 100010, China
2. China Academy of Chinese Medical Sciences, Beijing 100700, China

Received date: 2023-04-01

Revised date: 2023-05-12

Online published: 2023-08-15

Fold

摘要

受近代西方科学的冲击与影响，中医药的优势评价和价值论证仍处在探索阶段，尚缺乏体现中医药特点的系统评价体系和现代评价手段。借鉴当前国际上在综合评价医疗保健绩效时所广泛使用的“价值医疗”理论和评价框架，提出将“价值”作为中医药优势评价的核心指标，并将其测量和评价分为疗效（包括生存状态、恢复情况和疗效巩固3个层次）、成本、患者体验和依从性3个方面来反映中医药优势评价的多维性，通过脑卒中和肺癌2类中医药优势病症的现有研究论证了价值医疗理论框架对于中医药优势评价的适配性，为中医药优势的综合评价和证据的系统整合提供与国际接轨的框架与思路。

关键词： 价值医疗; 中医药; 优势评价; 疗效与成本; 患者体验与依从性

本文引用格式

郭然 , 曾典 , 胡裕涵 , 刘远立 , 刘保延 . 价值医疗视角下的中医药优势评价思路与方法[J]. 科技导报, 2023 , 41(14) : 14 -21 . DOI: 10.3981/j.issn.1000-7857.2023.14.002

Abstract

The purpose of this study is to fill the gaps in the scientific and systematic evaluation of the advantages of Traditional Chinese Medicine (TCM) by modern evaluation methods. In recent years, "Value-based healthcare" is a theoretical framework widely used in the comprehensive evaluation of healthcare performance. It advocates patients-centered integrated practice units, emphasizes cost-effective medical services, and pays attention to clinical indicators, functional status and rehabilitation of patients in the outcome measurement, which is consistent with the characteristics of TCM "people-oriented, from the function of the human body to grasp and regulate the life activities of the human body". Therefore, the evaluation method based on value-based healthcare has reference significance for the evaluation of TCM. Based on the theory and evaluation framework of value-based healthcare, this study proposes to take "value" as the core index of TCM advantage evaluation, and divides its measurement and evaluation into three aspects, namely efficacy, cost, patient experience and compliance, to reflect the multi-dimension of TCM advantage evaluation. The applicability of the theoretical framework of value medicine to the evaluation of the advantages of TCM was demonstrated through the existing studies on stroke and lung cancer, thus providing an international framework and ideas for the comprehensive evaluation of the advantages of TCM and the systematic integration of literature.

Key words： value-based healthcare; Traditional Chinese Medicine; advantage evaluation; efficacy and cost; patient experience and compliance

参考文献

[1] 构建起强大的公共卫生体系为维护人民健康提供有力保障 [EB/OL]. (2020-09-15) [2023-02-01]. http://www.qstheory.cn/dukan/qs/2020-09/15/c_1126493739.htm.
[2] 季聪华, 郭清 . 基于循证医学的中医优势病种评价标准思考[J]. 中华中医药杂志, 2022, 37(1): 277-280.
[3] 林奕, 王学谦, 赵晖, 等. 中医优势病种评价的方法学探讨[J]. 中医杂志, 2021, 62(19): 1663-1667.
[4] 黎鹏程, 何清湖, 孙贵香, 等 . 国医大师孙光荣论“中医优势病种”[J]. 湖南中医药大学学报, 2018, 38(1): 1-3.
[5] 王洋. 中医临床个性化疗效评价内涵解析及体系构建研究[D]. 福州: 福建中医药大学, 2018.
[6] Lam T P, Sun K S. Dilemma of integration with western medicine-Views of Traditional Chinese Medicine practitioners in a predominant western medical setting[J]. Complementary Therapies in Medicine, 2013, 21(4): 300-305.
[7] Porter M E, Larsson S, Lee T H. Standardizing patient outcomes measurement[J]. New England Journal of Medicine, 2016, 374(6): 504-506.
[8] Porter M E, Teisberg E O. Redefining health care: Creating value-based competition on results[M]. Cambridge: Harvard Business Press, 2006.
[9] Institute of Medicine. Crossing the quality chasm: A new health system for the 21st century[M]. Washington DC: National Academies Press, 2001
[10] Porter M E. What is value in health care[J]. New England Journal of Medicine, 2010, 363(26): 2477-2481.
[11] Porter M E, Seminar V I. Value-based health care delivery: Core concepts[EB/OL]. (2019-08-05) [2023-02-01]. https://www. isc. hbs. edu/Documents/pdf/value-based-healthcare-core-concepts.
[12] ICHOM. Standard sets-ICHOM connect[EB/OL]. (2022-12-12)[2022-12-25]. https://connect.ichom. org/patientcentered-outcome-measures.
[13] Hurst L. Defining value-based healthcare in the NHSORA-Oxford University research archive[EB/OL].(2022-11-26)[2022-12-12]. https://ora.ox.ac.uk/objects/uuid:2ab0a667-2a14-4242-a30f-1bdbeaad95ef.
[14] 蒋海泥, 王留明, 杜杏利, 等 . 新形势下我国价值导向型医疗服务体系构建[J]. 中国医院, 2018, 22(4): 19-21.
[15] Ceylan-isik A F, Fliethman R M, Wold L E, et al. Herbal and Traditional Chinese Medicine for the treatment of cardiovascular complications in diabetes mellitus[J]. Current Diabetes Reviews, 2008, 4(4): 320-328.
[16] 宋永嘉, 王凯, 宋敏. 基于价值医疗理念的慢性筋骨病中医药防治优势分析[J]. 甘肃中医药大学学报, 2020, 37(1): 60-63.
[17] Zhang F, Kong L, Zhang Y, et al. Evaluation of impact on health-related quality of life and cost effectiveness of Traditional Chinese Medicine: A systematic review of randomized clinical trials[J]. The Journal of Alternative and Complementary Medicine, 2012, 18(12): 1108- 1120.
[18] Tao W, Luo X, Cui B, et al. Practice of Traditional Chinese Medicine for psycho-behavioral intervention improves quality of life in cancer patients: A systematic review and meta-analysis[J]. Oncotarget, 2015, 6(37): 39725-39739.
[19] 孙立明. 关于中医优势病种研究的评述和建议[J]. 中华中医药杂志, 2022, 37(3): 1271-1273.
[20] 季聪华. 中医优势病种的卫生经济学评价[J]. 中国卫生经济, 2012, 31(11): 67-69.
[21] 方旖旎, 王琦, 张国辉, 等 . 中医体质学在“治未病”中的应用研究[J]. 中医杂志, 2020, 61(7): 581-585.
[22] 叶虹, 肖英超, 曹立幸, 等 . 文献研究结合访谈探析陈志强围手术期中医药应用思路[J]. 广州中医药大学学报, 2022, 39(12): 2926-2932.
[23] 刘同心 .“循证+价值医疗”视角下中医优势病种的卫生经济学研究[D]. 长沙: 湖南中医药大学, 2022.
[24] Dai Z, Liao X, Wieland L S, et al. Cochrane systematic reviews on Traditional Chinese Medicine: What mattersthe quantity or quality of evidence[J]. Phytomedicine, 2022, 98: 153921.
[25] 张洪岐, 马冲, 刘颖 . 中医药防治艾滋病研究述评[J].中国中医基础医学杂志, 2022, 28(12): 2071-2074.
[26] 胡广宇, 吴来阳, 孙静, 等. 我国136所三级医院门诊患者满意度调查[J]. 中华医院管理杂志, 2016, 32(6):423-427.
[27] 郭然, 胡琳琳, 刘美岑, 等 . 北京市区级医院门诊患者满意度及影响因素分析[J]. 医学与社会, 2021, 34(11): 26-31.
[28] Li X, Yang G, Li X, et al. Traditional Chinese Medicine in cancer care: A review of controlled clinical studies published in Chinese[J]. PLoS One, 2013, 8(4): e60338.
[29] Salinas J, Sprinkhuizen S M, Ackerson T, et al. An international standard set of patient-centered outcome measures after stroke[J]. Stroke, 2016, 47(1): 180-186.
[30] Li J, Zhao X, Zhang Y, et al. Comparison of Traditional Chinese Medicine in the long-term secondary prevention for patients with ischemic stroke: A systematical analysis[J]. Frontiers in Pharmacology, 2021, 12: 722975.
[31] Ge L, Zheng Q, Liao Y, et al. Effects of traditional Chinese exercises on the rehabilitation of limb function among stroke patients: A systematic review and meta-analysis[J]. Complementary Therapies in Clinical Practice, 2017, 29: 35-47.
[32] Yang Y, Zhang M, Zhao J, et al. Effect of Traditional Chinese Medicine emotional therapy on post-stroke depression[J]. Medicine, 2021, 100(14): e25386.
[33] Yang A, Wu H M, Tang J L, et al. Acupuncture for stroke rehabilitation[J]. Cochrane Database of Systematic Reviews, 2016(8): CD004131.
[34] 郑薏, 柳维林, 上官豪, 等 . 针灸治疗脑卒中患者肢体运动功能障碍疗效的 Meta 分析[J]. 中国康复医学杂志, 2016, 31(2): 217-221.
[35] Yi L, Li C, Irene J S. Effectiveness of auricular acupressure for post-stroke constipation: A systematic review and meta-analysis[J]. Journal of Alternative, Complementary & Integrative Medicine, 2021, 7(6): 1-8..
[36] Shih C C, Liao C C, Sun M F, et al. A retrospective cohort study comparing stroke recurrence rate in ischemic stroke patients with and without acupuncture treatment[J]. Medicine, 2015, 94(39): e1572.
[37] 夷青 . 中医针灸疗法治疗脑卒中的成本效益分析[D].南京: 南京中医药大学, 2016.
[38] Mak K S, Vanbommel A C M, Stowell C, et al. Defining a standard set of patient-centred outcomes for lung can⁃cer[J]. The European Respiratory Journal, 2016, 48(3): 852-860.
[39] Jiang Y, Liu L S, Shen L P, et al. Traditional Chinese Medicine treatment as maintenance therapy in advanced non-small-cell lung cancer: A randomized controlled trial[J]. Complementary Therapies in Medicine, 2016, 24: 55-62.
[40] Wang S F, Wang Q, Jiao L J, et al. Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: A systemic review and meta-analysis[J]. Current Oncology, 2016, 23(3): 188-195.
[41] 张素芳 . 中医药对非小细胞肺癌根治术后患者生存期及免疫功能影响的临床研究[D]. 上海: 上海中医药大学, 2020
[42] 何春霞 . 非小细胞肺癌住院病例的成本—效果回顾性研究[D]. 广州: 广州中医药大学, 2008.
[43] 习近平致中国中医科学院成立 60 周年贺信[EB/OL]. (2015-12-22) [2022-12-25]. http://www. gov. cn/xinwen/2015-12/22/content_5026645.htm.
[44] Hu C, Qin X, Ye R, et al. The role of Traditional Chinese Medicine nursing for stroke: An umbrella review[J]. Evidence-Based Complementary and Alternative Medicine, 2021, 2021: 1-12.
[45] Wu M, Hu J, Liu B. The reporting quality assessment of complex interventions' articles in Traditional Chinese Medicine[J]. Evidence-Based Complementary and Alternative Medicine, 2013(1): 1-8.
[46] 张新苹. 中医医疗服务项目的定价机制研究[J]. 上海中医药大学学报, 2022, 36(Supp1 1): 264-267, 295.
[47] 苏淑文, 王冬 . 价值导向型医疗研究进展及其启示[J].中国卫生经济, 2018, 37(5): 71-74.
[48] Makary M A, Daniel M. Medical error—The third leading cause of death in the US[J]. BMJ, 2016(353): 2139.
[49] Napier A D, Ancarno C, Butler B, et al. Culture and health[J]. The Lancet, 2014, 384(9954): 1607-1639.
[50] Horne R, Graupner L, Frost S, et al. Medicine in a multi-cultural society: The effect of cultural background on beliefs about medications[J]. Social Science & Medicine, 2004, 59(6): 1307-1313.

Options

文章导航

摘要

本文引用格式

Abstract

参考文献

联系我们

访问统计

模态框（Modal）标题

摘要

本文引用格式

Abstract

参考文献

联系我们

访问统计